Invicta Diagnostic Limited (NSE:INVICTA)
India · Delayed Price · Currency is INR 68.15
+1.40 (2.10%)
At close: Jul 31, 2026
Invicta Diagnostic Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 222.13 | 21.62 | 13.36 | 0.44 | 3.54 |
Cash & Short-Term Investments | 222.13 | 21.62 | 13.36 | 0.44 | 3.54 |
Cash Growth | 927.63% | 61.81% | 2923.12% | -87.50% | 541.80% |
Accounts Receivable | 5.73 | 14.56 | 8.55 | 0.05 | 0.01 |
Receivables | 110.72 | 14.56 | 20.18 | 0.05 | 0.01 |
Inventory | 5.94 | 5.03 | 3.94 | - | - |
Prepaid Expenses | - | 0.05 | - | - | - |
Other Current Assets | 4.28 | 22.63 | 0.49 | 28.09 | 26.61 |
Total Current Assets | 343.08 | 63.88 | 37.97 | 28.58 | 30.16 |
Property, Plant & Equipment | 191.9 | 95.7 | 117.3 | 30.39 | 48.54 |
Long-Term Investments | 61.98 | 43.34 | - | - | - |
Other Intangible Assets | 0.09 | 0.11 | 0.16 | - | - |
Other Long-Term Assets | 5.46 | 9.13 | 3.45 | 2.25 | 2.15 |
Total Assets | 602.49 | 212.17 | 158.87 | 61.22 | 80.84 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 19.01 | 4.17 | 14.51 | 3.02 | 3.93 |
Accrued Expenses | 28.29 | 7.93 | 7.9 | - | - |
Short-Term Debt | 24.3 | - | - | - | - |
Current Income Taxes Payable | - | 14.88 | 1.02 | - | - |
Other Current Liabilities | 0 | - | - | 2.56 | 2.28 |
Total Current Liabilities | 71.6 | 26.98 | 23.43 | 5.59 | 6.2 |
Long-Term Debt | 12.41 | 35.38 | 38.11 | 0.1 | 4 |
Pension & Post-Retirement Benefits | 1.08 | 0.94 | 0.25 | - | - |
Long-Term Deferred Tax Liabilities | 18.17 | 12.88 | 10.4 | - | - |
Other Long-Term Liabilities | -0 | - | - | - | - |
Total Liabilities | 103.26 | 76.18 | 72.18 | 5.69 | 10.2 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 125.72 | 84.18 | 1.32 | 55.54 | 70.64 |
Additional Paid-In Capital | - | - | 52.18 | - | - |
Retained Earnings | - | 62.07 | 43.84 | - | - |
Comprehensive Income & Other | 373.51 | - | - | - | - |
Total Common Equity | 499.23 | 146.25 | 97.33 | 55.54 | 70.64 |
Minority Interest | - | -10.26 | -10.64 | - | - |
Shareholders' Equity | 499.23 | 135.98 | 86.69 | 55.54 | 70.64 |
Total Liabilities & Equity | 602.49 | 212.17 | 158.87 | 61.22 | 80.84 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 36.71 | 35.38 | 38.11 | 0.1 | 4 |
Net Cash (Debt) | 185.42 | -13.77 | -24.76 | 0.34 | -0.46 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | 18.52 | -1.64 | -2.94 | - | - |
Filing Date Shares Outstanding | 11.12 | 9.26 | 11.43 | - | - |
Total Common Shares Outstanding | 11.12 | 8.42 | 8.42 | - | - |
Working Capital | 271.48 | 36.9 | 14.55 | 23 | 23.95 |
Book Value Per Share | 44.88 | 17.37 | 11.56 | - | - |
Tangible Book Value | 499.14 | 146.13 | 97.18 | 55.54 | 70.64 |
Tangible Book Value Per Share | 44.87 | 17.36 | 11.54 | - | - |
Buildings | - | 0.64 | 0.64 | - | - |
Machinery | - | 209.68 | 206.41 | 49.41 | 79.7 |